Want to join the conversation?
Biotechnology company $AMGN said at the European Society of Cardiology (ESC) Congress 2016 it has presented data showing that its human monoclonal antibody Repatha (evolocumab) consistently reduced low-density lipoprotein cholesterol (LDL-C) in patients with familial hypercholesterolemia.
What are your expectations from $COKE tomorrow?? Will the bear attack the beverage?
People seem to be cold about the $HAL earnings! Honestly, I expected more stock action by now.
$TSLA's Musk says Neuralink will take on AI prominence. Apparently, he wants to avoid a "Terminator" kind situation.
$JCP shares rebounded and now in green territory after saying it will hire 800 consultants as part of a beauty expansion that will include 70 new Sephora store-in-store locations.